Francesco Coco-Lococo

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Corrigendum to "STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype" [Leuk. Res. 78 (2019) 21-23].

Corrigendum to "STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype" [Leuk. Res. 78 (2019) 21-23].

Journal: Leukemia research
Published: May 09, 2020

STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype.

STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype.

Journal: Leukemia research
Published: January 07, 2019

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia.

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia.

Journal: Leukemia
Published: July 06, 2018

Towards home-based treatment for acute promyelocytic leukaemia, with caution.

Towards home-based treatment for acute promyelocytic leukaemia, with caution.

Journal: The Lancet. Oncology
Published: May 03, 2018

Molecular remission as a therapeutic objective in acute promyelocytic leukemia.

Molecular remission as a therapeutic objective in acute promyelocytic leukemia.

Journal: Leukemia
Published: March 20, 2018

Targeted Therapy Alone for Acute Promyelocytic Leukemia.

Targeted Therapy Alone for Acute Promyelocytic Leukemia.

Journal: The New England journal of medicine
Published: March 24, 2016

Current management of newly diagnosed acute promyelocytic leukemia.

Current management of newly diagnosed acute promyelocytic leukemia.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 08, 2016

Cost-Effectiveness Analysis of Treating Acute Promyelocytic Leukemia Patients With Arsenic Trioxide and Retinoic Acid in the United States.

Cost-Effectiveness Analysis of Treating Acute Promyelocytic Leukemia Patients With Arsenic Trioxide and Retinoic Acid in the United States.

Journal: Clinical lymphoma, myeloma & leukemia
Published: July 07, 2015

Understanding the molecular pathogenesis of acute promyelocytic leukemia.

Understanding the molecular pathogenesis of acute promyelocytic leukemia.

Journal: Best practice & research. Clinical haematology
Published: June 08, 2014

What is the standard regimen for patients with acute promyelocytic leukemia?

What is the standard regimen for patients with acute promyelocytic leukemia?

Journal: Current hematologic malignancy reports
Published: April 15, 2014

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Journal: The New England journal of medicine
Published: July 12, 2013

Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group.

Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group.

Journal: Blood
Published: July 21, 2010
Showing 1-12 of 19

Last Updated: 09/26/2026